Proposed ‘drug price’ changes threaten access for Canadian patients

Author:

Kristina M.L. Acri, née Lybecker

Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.Read more about Proposed ‘drug price’ changes threaten access for Canadian patients Tags: pmprbcanadian drug pricesdrug costsnew drug regulationspatented drugs

Read More - The Fraser Institute